Purchase Short-Term Access

In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD

Annals of Internal Medicine 2011;154:JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.